DCM Shriram Fine Chemicals
- P/E
- Not meaningful: loss-making over the last twelve months
Key Fundamentals
MicrocapPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 0.31%
- Debt to Equity
- 0.07
- EPS (TTM)
- −₹0.65
- Book Value
- ₹24.26
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 1.13
- ROE
- −0.53%
- Dividend Yield
- 1.48%
- EBITDA
- ₹6.80 Cr
- 52W High
- ₹52.50
- 52W Low
- ₹17.28
- Day Range
- ₹25.98 – ₹28.24
- Volume
- 65,149
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
DCM Shriram Fine Chemicals (this company) | ₹27.53 | — | ₹226 Cr | 1.13 | 1.48% | −0.53% | 0.31% | ₹378 Cr | −₹6 Cr |
| Median 8 companies | ₹1,559.55 | 57.03 | ₹20,474 Cr | 4.68 | 0.36% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- Company has low interest coverage ratio.
- Earnings include an other income of Rs.2.31 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 7 | 10 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 0 | 2 | 8 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 54.79
- Neutral
- MACD (12,26,9)
- −0.34
- Bullish
- SMA (50)
- 27.08
- Bullish
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 1Y | −10.02% |
|---|
Net profit
| 1Y | Turned to loss |
|---|
Operating cash flow
| 1Y | +6.67% |
|---|
Operating margin· change in pp
| 1Y | −5.88 pp |
|---|
Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2025 | ₹429 Cr |
|---|---|
| Mar 2026 | ₹386 Cr |
Net profit by year
| Mar 2025 | ₹18.00 Cr |
|---|---|
| Mar 2026 | −₹4.00 Cr |
Quarterly Results
₹ Cr| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 93.35 | 113 | 98.62 | 96.9 | 96.95 | 93.08 | 90.78 |
| Expenses | 88.47 | 105 | 91.29 | 98.39 | 96.63 | 95.58 | 85.68 |
| Operating Profit | 4.88 | 7.92 | 7.33 | −1.49 | 0.32 | −2.5 | 5.1 |
| OPM % | 5.23% | 7% | 7.43% | −1.54% | 0.33% | −2.69% | 5.62% |
| Other Income | 0.72 | 0.75 | 0.67 | 0.42 | 0.64 | 0.43 | 0.82 |
| Interest | 0.41 | 0.79 | 0.29 | 0.22 | 0.24 | 0.69 | 0.44 |
| Depreciation | 2.2 | 2.16 | 2.16 | 2.17 | 2.11 | 2.06 | 1.95 |
| PBT | 2.99 | 5.72 | 5.55 | −3.46 | −1.39 | −4.82 | 3.53 |
| Tax % | 26.42% | 25.35% | 25.41% | −21.39% | 16.55% | −15.35% | 31.44% |
| Net Profit | 2.2 | 4.27 | 4.13 | −2.72 | −1.62 | −4.08 | 2.42 |
| EPS (₹) | 0.22 | 0.43 | 0.41 | −0.27 | −0.19 | −0.47 | 0.28 |
Profit & Loss
₹ Cr| Particulars | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 429 | 386 | 378 |
| Expenses | 396 | 379 | 376 |
| Operating Profit | 33 | 7 | 1 |
| OPM % | 8% | 1.8% | 0.4% |
| Other Income | 3 | −1 | 2 |
| Interest | 2 | 1 | 2 |
| Depreciation | 9 | 8 | 8 |
| PBT | 25 | −4 | −6 |
| Tax % | 26% | 4% | — |
| Net Profit | 18 | −4 | −6 |
| EPS (₹) | 1.85 | −0.49 | −0.65 |
| Div. Payout % | 0% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — |
Balance Sheet
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 0 | 17 |
| Reserves | 205 | 183 |
| Borrowings | 13 | 13 |
| Other Liabilities | 80 | 72 |
| Total Liabilities | 298 | 285 |
| Fixed Assets | 131 | 103 |
| CWIP | 0 | 0 |
| Investments | 27 | 38 |
| Other Assets | 140 | 143 |
| Total Assets | 298 | 285 |
Cash Flow
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | 15 | 16 |
| Investing | 0 | 10 |
| Financing | −15 | −6 |
| Net Cash Flow | 0 | 21 |
| Free Cash Flow | 12 | 36 |
| CFO/OP | 72 | 293 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 70 | 67 |
| Inventory Days | 74 | 64 |
| Days Payable | 80 | 78 |
| Cash Conversion Cycle | 65 | 53 |
| Working Capital Days | 52 | 46 |
| ROCE % | — | 0% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view DCM Shriram Fine Chemicals insights
33 extracted metrics across FY24–FY27.
Documents
- 7 Apr 2026
- General announcements 8 Oct 2026
Frequently Asked Questions about DCM Shriram Fine Chemicals
What does DCM Shriram Fine Chemicals Ltd do?
Where is DCM Shriram Fine Chemicals Ltd (DSFCL) listed?
Which sector does DCM Shriram Fine Chemicals Ltd belong to?
What is the 52-week high and low of DCM Shriram Fine Chemicals Ltd?
Does DCM Shriram Fine Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of DCM Shriram Fine Chemicals Ltd?
Company Information
DCM Shriram Ltd is a producer of Pharmaceutical Intermediates, particularly in the Anti-Infective segment using Optical Isomer separation as its core competence.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544703.md for DCM Shriram Fine Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.